Variant report
Variant | esv3407893 |
---|---|
Chromosome Location | chr3:154780208-154782456 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79183877 | chr3:154780228-154780229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547166742 | chr3:154780232-154780233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559024421 | chr3:154780234-154780235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529700057 | chr3:154780278-154780279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547798369 | chr3:154780354-154780355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115116800 | chr3:154780418-154780419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140008775 | chr3:154780539-154780540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145446046 | chr3:154780563-154780564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570713819 | chr3:154780592-154780593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147835044 | chr3:154780593-154780594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553158979 | chr3:154780611-154780612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191687291 | chr3:154780622-154780623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373804106 | chr3:154780623-154780624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562141616 | chr3:154780675-154780676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557414042 | chr3:154780717-154780718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148866212 | chr3:154780718-154780719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367692598 | chr3:154780723-154780724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529675538 | chr3:154780748-154780749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546165252 | chr3:154780749-154780750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6778554 | chr3:154780786-154780787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573436285 | chr3:154780787-154780788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560216250 | chr3:154780835-154780836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540435807 | chr3:154780848-154780849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561911850 | chr3:154780854-154780855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113256180 | chr3:154780892-154780893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201058424 | chr3:154780913-154780914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529759117 | chr3:154780920-154780921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs151003135 | chr3:154780925-154780926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541550125 | chr3:154780954-154780955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200059141 | chr3:154780987-154780988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541473222 | chr3:154781017-154781018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563379895 | chr3:154781028-154781029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530462678 | chr3:154781042-154781043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552149667 | chr3:154781043-154781044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533514165 | chr3:154781073-154781074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374912875 | chr3:154781137-154781138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531502413 | chr3:154781140-154781141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533824793 | chr3:154781151-154781152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539167525 | chr3:154781176-154781177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371663338 | chr3:154781255-154781256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372270018 | chr3:154781263-154781264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376836326 | chr3:154781264-154781265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369413530 | chr3:154781271-154781272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372395032 | chr3:154781275-154781276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375633353 | chr3:154781277-154781278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs28625536 | chr3:154781356-154781357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9758635 | chr3:154781404-154781405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9757498 | chr3:154781405-154781406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111442074 | chr3:154781409-154781410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs28683517 | chr3:154781411-154781412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Bladder cancer | 21909424 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:154774600-154788800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr3:154778600-154782400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr3:154778600-154787000 | Weak transcription | Placenta Amnion | Placenta Amnion |
4 | chr3:154781600-154782200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr3:154781600-154782600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr3:154781600-154783800 | Enhancers | K562 | blood |
7 | chr3:154781600-154784600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr3:154781800-154784800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr3:154782200-154783800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr3:154782200-154783800 | Enhancers | Adipose Nuclei | Adipose |
11 | chr3:154782200-154784400 | Enhancers | HSMM | muscle |
12 | chr3:154782200-154784600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr3:154782200-154784800 | Enhancers | NHDF-Ad | bronchial |
14 | chr3:154782400-154784000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr3:154782400-154784200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr3:154782400-154784400 | Enhancers | NHLF | lung |
17 | chr3:154782400-154784600 | Enhancers | Muscle Satellite Cultured Cells | -- |
18 | chr3:154782400-154784600 | Enhancers | HSMMtube | muscle |